L'un des principaux objectifs de Life4me + - est de prévenir de nouveaux cas de VIH et d'autres IST, d'hépatite C et de tuberculose.

L'application aide à établir une communication anonyme entre les médecins et les personnes séropositives. Elle vous permet d'organiser facilement votre horaire de prise de médicaments et de définir des rappels cachés et personnalisés.

Toutes les actualités

Archive

✕

9 juillet 2020, 11:34

627

Global study confirms holistic approach to HIV care improves quality of life

Global study confirms holistic approach to HIV care improves quality of life

ViiV Healthcare’s Positive Perspectives Wave 2 study has shown that higher levels of engagement between healthcare providers and people living with HIV are associated with better health outcomes. The company presented four abstracts at the virtual AIDS 2020 conference ...

9 juillet 2020, 10:19

562

First person with HIV in long-term remission without stem cell transplant

First person with HIV in long-term remission without stem cell transplant

A Brazilian man shows no evidence of HIV remaining in his body after over a year off HIV antiretrovirals, but researchers say it's too early to speak of a functional cure. SPARC-7 study recruited HIV positive adults who were still on their first HIV antiretroviral combination ...

9 juillet 2020, 09:28

512

Study finds injectable PrEP to be more effective than daily oral PrEP

Study finds injectable PrEP to be more effective than daily oral PrEP

Data presented at AIDS 2020 Virtual has shown that in a recent study ViiV Healthcare’s long-lasting injectable Cabotegravir was more effective at preventing HIV than the already highly effective Truvada. 4,570 cisgender men who have sex with men and transgender women ...

6 juillet 2020, 14:52

578

UNAIDS reports that global 2020 targets will not be met, and COVID-19 could make things even worse

UNAIDS reports that global 2020 targets will not be met, and COVID-19 could make things even worse

The latest report from UNAIDS shows that whilst remarkable progress has been made that progress has been highly unequal especially when it comes to access to HIV treatment. As a result of this the global targets set for 2020 will not be reached. The report, Seizing the ...

6 juillet 2020, 14:03

551

Another HIV duo-therapy option proves effective at 48 weeks

Another HIV duo-therapy option proves effective at 48 weeks

People living with HIV could soon have another duo-therapy option available to them after promising data presented at Virtual AIDS 2020. MSD (Merck) showed off data from their DRIVE2Simplify study which showed the combination of islatravir and doravirine (Pifeltro) maintained ...

3 juillet 2020, 09:56

646

New HIV treatment option for those with multi-drug resistance approved by FDA

New HIV treatment option for those with multi-drug resistance approved by FDA

ViiV Healthcare’s Rukobia (fostemsavir) has been approved by the US Food and Drug Administration (FDA) as a treatment for HIV in adults with multi-drug resistance or other safety concerns. This new one tablet twice daily Rukobia regimen marks a real breakthrough for heavily ...

30 juin 2020, 13:00

686

No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients

No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients

The RECOVERY trial was set up in March 2020 to test a wide range of existing potential treatments for COVID-19, one of which was lopinavir & ritonavir (HIV anti-retrovirals commonly known as Kaletra). Over 11,800 patients from 176 NHS hospitals in the UK were enrolled into ...

24 juin 2020, 09:51

778

Welsh Rugby star Gareth Thomas launches new stigma campaign with ViiV and THT

Welsh Rugby star Gareth Thomas launches new stigma campaign with ViiV and THT

Welsh Rugby star Gareth Thomas and ViiV Healthcare launch 'Tackle HIV' campaign to a public misunderstanding and stigma associated with HIV. Results from a recent UK wide survey of 4,000 adults demonstrated that misunderstanding and stigma still continue to exist despite ...

9 juin 2020, 12:20

1112

HIV viral load rebounds rapidly in semen ARVs are stopped study says

HIV viral load rebounds rapidly in semen ARVs are stopped study says

Researchers studying HIV therapeutic vaccines have found that when patients were taken off their HIV antiretrovirals (ARV) that the levels of virus in their semen rebounded rapidly. An analysis was carried out, following 10 male participants in the VRI02 trial who also ...

9 juin 2020, 11:28

1031

COVID-19 Lockdown could help us end HIV transmission

COVID-19 Lockdown could help us end HIV transmission

As the world continues to fight the COVID-19 pandemic one unexpected silver lining to the imposed lockdowns and quarantines is that we’re seeing fewer new HIV infections. Whilst countries around the globe enforced lockdowns and quarantines on its peoples to prevent the ...

1 2 3...97